Insulin monotherapy compared with the addition of oral glucose‐lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Insulin Monotherapy Compared With the Addition of Oral Glucose‐lowering Agents to Insulin for People With Type 2 Diabetes Already On Insulin Therapy and Inadequate Glycaemic Control." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/431259/all/Insulin_monotherapy_compared_with_the_addition_of_oral_glucose‐lowering_agents_to_insulin_for_people_with_type_2_diabetes_already_on_insulin_therapy_and_inadequate_glycaemic_control.
Insulin monotherapy compared with the addition of oral glucose‐lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431259/all/Insulin_monotherapy_compared_with_the_addition_of_oral_glucose‐lowering_agents_to_insulin_for_people_with_type_2_diabetes_already_on_insulin_therapy_and_inadequate_glycaemic_control. Accessed February 14, 2025.
Insulin monotherapy compared with the addition of oral glucose‐lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431259/all/Insulin_monotherapy_compared_with_the_addition_of_oral_glucose‐lowering_agents_to_insulin_for_people_with_type_2_diabetes_already_on_insulin_therapy_and_inadequate_glycaemic_control
Insulin Monotherapy Compared With the Addition of Oral Glucose‐lowering Agents to Insulin for People With Type 2 Diabetes Already On Insulin Therapy and Inadequate Glycaemic Control [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 February 14]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/431259/all/Insulin_monotherapy_compared_with_the_addition_of_oral_glucose‐lowering_agents_to_insulin_for_people_with_type_2_diabetes_already_on_insulin_therapy_and_inadequate_glycaemic_control.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Insulin monotherapy compared with the addition of oral glucose‐lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control
ID - 431259
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/431259/all/Insulin_monotherapy_compared_with_the_addition_of_oral_glucose‐lowering_agents_to_insulin_for_people_with_type_2_diabetes_already_on_insulin_therapy_and_inadequate_glycaemic_control
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -